Pioneering transformational drug discovery and development in the areas of cancer and fibrosis
RXC004 Oncology – Clinical Phase 1/2 study ongoing
Pioneering transformational drug discovery and development in the areas of cancer and fibrosis
RXC006 - Potential first-in-class Porcupine inhibitor for fibrosis
Pioneering transformational drug discovery and development in the areas of cancer and fibrosis
RXC007 – Potential best-in-class ROCK2 inhibitor for multiple fibrotic diseases
Pioneering transformational drug discovery and development in the areas of cancer and fibrosis
GI-targeted ROCK – Potential first-in-class for Crohn’s disease-associated fibrosis
